Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal

April 27, 2026 2:10 PM

Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal

India’s major drugmaker Sun Pharmaceutical Industries on Monday announced that it will acquire New York-listed Organon & Co in an all-cash deal valued at $11.75 billion, its biggest overseas acquisition to date. Under the agreement, the pharmaceutical firm will acquire 100 per cent of Organon’s outstanding shares at $14 per share, translating into an enterprise valuation of $11.75 billion and an equity value of around $3.99 billion, the company said in an exchange filing. The company s...

BSE clocks 174 per cent jump in Q3 net profit

February 9, 2026 9:57 PM

BSE clocks 174 per cent jump in Q3 net profit

BSE reported a 174 per cent jump in its consolidated net profit at Rs 602 crore for the October-December quarter (Q3) of 2025-26, compared with the corresponding figure of Rs 220 crore reported in the same quarter of the previous year. The net profit margin of the stock exchange expanded sharply to 45 per cent from 26 per cent. India’s oldest stock exchange also recorded an all-time high quarterly revenue of Rs 1,334 crore in Q3 FY26, representing a robust 61 per cent year‑on‑year increa...

Paytm registers 25% growth in revenue at Rs 9,978 crore in 2023-24

September 16, 2024 6:43 PM

Paytm registers 25% growth in revenue at Rs 9,978 crore in 2023-24

Paytm, the leading fintech brand operated by One 97 Communications, has reported a 25% surge in revenue, reaching Rs 9,978 crore during the financial year 2023-24. The company attributed the growth to the increasing gross merchandise value (GMV), expansion of merchant devices, and the flourishing financial services distribution business. Paytm achieved EBITDA profitability before ESOP costs of Rs 559 crore for the first full year since its initial public offering (IPO). During the fourth quart...